$GENTING (3182.MY)$
taurx delay the answer to MHRA，hopefully they will submit in March and the approval from NICE come before June

$SUNZEN (0148.MY)$
once the dispose of animal division completed，the only direction is north

$SUNZEN-WC (SUNZEN GROUP BHD) (0148WC.MY)$
take out the loss from animal devision，PAT will be 3m

$SUNZEN (0148.MY)$
next Quarter profits surely crazy，2.25m + 3m =5m++
forwards ，no more loss from animal division，more capital to  make profits，4 m /quarter  will  lift share price to 0.6 atleast

$DRBHCOM (1619.MY)$
Perodua's technology in EV obviously cannot lower costs, Proton is very likely to defeat Perodua to become the first in Malaysia.

$SUNZEN (0148.MY)$
Did you buy the tickets? The swallows are about to take off.

$BJFOOD (5196.MY)$
break down trend，flying mode

$GENTING (3182.MY)$
forming head ＆ shoulder bottom？

$GENTING (3182.MY)$
Excluding other factors, assuming TauRx submits its data as scheduled in February, the stock price may experience a small uptick. By the end of March, if the MHRA approval is granted, the stock price could rise to a range of 4.4–4.8. If NICE grants approval in April, the stock price may break through the long-term resistance at 5.2.
If any of these three milestones encounters issues, the downside risk appears limited. Given that the potential benefits of TauRx are not yet ful...